This Afternoon's Top News Stories

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Here's a quick look at a few of the headlines making news this afternoon.

Norway rejects cigarette appeal
Philip Morris
(NYSE: PM  ) has lost a legal challenge of Norway's ban on displaying tobacco products in stores. Philip Morris had argued that the ban interfered with the free flow of goods and violated international agreements, according to an Associated Press report. The court concluded that "the display ban is necessary and that there aren't other, less invasive methods which could give similar results," reported the AP.

Management shuffle
Health Care REIT
(NYSE: HCN  ) plans to sell the management business of Sunrise Senior Living for $130 million, Reuters is reporting. The buyers are three private equity firms. Health Care REIT will turn around and buy a 20% interest in the new management business, according to Reuters. Health Care REIT is in the process of acquiring Sunrise Senior Living.

Teva animal health division finds buyer
Bayer HealthCare will acquire Teva Pharmaceutical's (NYSE: TEVA  ) U.S.-based animal health business for up to $145 million, the companies announced today. The purchase price includes an upfront payment of $60 million plus a total of $85 million in milestone payments. If regulatory hurdles are cleared, the companies expect to close the sale in 2013. It involves a manufacturing site in Missouri and about 300 employees.

NYSE pays for data-feed disparity
The New York Stock Exchange will pay $5 million to settle federal charges that it provided select traders with data ahead of the rest of the public. The matter involved data feeds and the disparities in data release times ranged from single-digit milliseconds to multiple seconds, according to an SEC press release. This marks "the first-ever SEC financial penalty against an exchange," according to the press release. editor Kris Eddy does not own shares of either company mentioned in this article. Motley Fool newsletter services have recommended buying shares of Health Care REIT. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.

Read/Post Comments (0) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2017402, ~/Articles/ArticleHandler.aspx, 10/28/2016 10:04:54 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,218.92 49.24 0.27%
S&P 500 2,134.70 1.66 0.08%
NASD 5,219.10 3.13 0.06%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/28/2016 9:49 AM
HCN $68.97 Up +0.57 +0.83%
Welltower CAPS Rating: ****
PM $96.56 Up +0.78 +0.81%
Philip Morris Inte… CAPS Rating: ****
TEVA $42.65 Down -0.50 -1.16%
Teva Pharmaceutica… CAPS Rating: ****